On this page

mnexspike

COVID-19 Vaccine, mRNA

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
mnexspike
Proper name
COVID-19 Vaccine, mRNA
Licence type
351(a)
BLA number
125835
Applicant
ModernaTX, Inc.
Center
CBER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
10UG Injection Intramuscular Pre-Filled Syringe Rx May 30, 2025

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity